![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1347913 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STXBP5 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | affects expression | ISO | RGD:1550059 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of STXBP5 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550059 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STXBP5 mRNA | CTD | PMID:21354282 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of STXBP5 mRNA | CTD | PMID:34747641 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of STXBP5 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of STXBP5 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1347913 | 6480464 | Lactic Acid results in decreased expression of STXBP5 mRNA | CTD | PMID:30851411 | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2, 6-dinitrotoluene affects the expression of STXBP5 mRNA | CTD | PMID:21346803 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of STXBP5 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases methylation | ISO | RGD:1347913 | 6480464 | Aflatoxin B1 results in increased methylation of STXBP5 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | RGD:1347913 | 6480464 | Tretinoin results in increased expression of STXBP5 mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of STXBP5 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | ISO | RGD:1347913 | 6480464 | Antirheumatic Agents results in increased expression of STXBP5 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:1347913 | 6480464 | aristolochic acid I results in decreased expression of STXBP5 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | ISO | RGD:1550059 | 6480464 | Benzo(a)pyrene results in decreased methylation of STXBP5 intron | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of STXBP5 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1550059 | 6480464 | bisphenol A results in decreased expression of STXBP5 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | ISO | RGD:1347913 | 6480464 | bisphenol A results in decreased expression of STXBP5 protein | CTD | PMID:33376534 | bisphenol A | decreases methylation | ISO | RGD:1347913 | 6480464 | bisphenol A results in decreased methylation of STXBP5 gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of STXBP5 gene | CTD | PMID:28505145 | cadmium atom | multiple interactions | ISO | RGD:1347913 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STXBP5 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1347913 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STXBP5 mRNA | CTD | PMID:35301059 | caffeine | decreases phosphorylation | ISO | RGD:1347913 | 6480464 | Caffeine results in decreased phosphorylation of STXBP5 protein | CTD | PMID:35688186 | CGP 52608 | multiple interactions | ISO | RGD:1347913 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to STXBP5 gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | RGD:1550059 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STXBP5 gene | CTD | PMID:20938992 | chromium(6+) | decreases expression | ISO | RGD:1347913 | 6480464 | chromium hexavalent ion results in decreased expression of STXBP5 mRNA | CTD | PMID:30690063 | cyclosporin A | increases expression | ISO | RGD:1347913 | 6480464 | Cyclosporine results in increased expression of STXBP5 mRNA | CTD | PMID:20106945, PMID:25562108 | dorsomorphin | multiple interactions | ISO | RGD:1347913 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1347913 | 6480464 | Doxorubicin results in decreased expression of STXBP5 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | RGD:1550059 | 6480464 | Ethanol affects the splicing of STXBP5 mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of STXBP5 mRNA | CTD | PMID:30307764 | folic acid | multiple interactions | ISO | RGD:1550059 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STXBP5 gene | CTD | PMID:20938992 | folic acid | decreases expression | ISO | RGD:1550059 | 6480464 | Folic Acid results in decreased expression of STXBP5 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | RGD:1347913 | 6480464 | Formaldehyde results in decreased expression of STXBP5 mRNA | CTD | PMID:23649840 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of STXBP5 mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | RGD:1347913 | 6480464 | Ivermectin results in decreased expression of STXBP5 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | RGD:1550059 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STXBP5 gene | CTD | PMID:20938992 | methylmercury chloride | decreases expression | ISO | RGD:1347913 | 6480464 | methylmercuric chloride results in decreased expression of STXBP5 mRNA | CTD | PMID:28001369 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of STXBP5 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | RGD:1550059 | 6480464 | Acetaminophen affects the expression of STXBP5 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of STXBP5 mRNA | CTD | PMID:33387578 | phenylmercury acetate | increases expression | ISO | RGD:1347913 | 6480464 | Phenylmercuric Acetate results in increased expression of STXBP5 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1347913 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP5 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | RGD:1550059 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STXBP5 mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | RGD:1347913 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STXBP5 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1347913 | 6480464 | potassium chromate(VI) results in decreased expression of STXBP5 mRNA | CTD | PMID:22079256, PMID:22714537 | potassium dichromate | increases expression | ISO | RGD:1550059 | 6480464 | Potassium Dichromate results in increased expression of STXBP5 mRNA | CTD | PMID:23608068 | quercetin | decreases expression | ISO | RGD:1347913 | 6480464 | Quercetin results in decreased expression of STXBP5 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | RGD:1347913 | 6480464 | Lactic Acid results in decreased expression of STXBP5 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | RGD:1347913 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenate | increases expression | ISO | RGD:1550059 | 6480464 | sodium arsenate results in increased expression of STXBP5 mRNA | CTD | PMID:21795629 | succimer | multiple interactions | ISO | RGD:1550059 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP5 mRNA | CTD | PMID:21641980 | tetrachloromethane | affects expression | ISO | RGD:1550059 | 6480464 | Carbon Tetrachloride affects the expression of STXBP5 mRNA | CTD | PMID:17484886 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of STXBP5 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of STXBP5 mRNA | CTD | PMID:25729387 | trichostatin A | increases expression | ISO | RGD:1347913 | 6480464 | trichostatin A results in increased expression of STXBP5 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1347913 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP5 mRNA | CTD | PMID:27188386 | trovafloxacin | decreases expression | ISO | RGD:1550059 | 6480464 | trovafloxacin results in decreased expression of STXBP5 mRNA | CTD | PMID:35537566 | tungsten | decreases expression | ISO | RGD:1550059 | 6480464 | Tungsten results in decreased expression of STXBP5 mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | RGD:1347913 | 6480464 | Urethane results in increased expression of STXBP5 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:1347913 | 6480464 | Valproic Acid results in decreased expression of STXBP5 mRNA | CTD | PMID:23179753, PMID:28001369 | |